TW202123978A - 抗癌劑暴露防止方法 - Google Patents

抗癌劑暴露防止方法 Download PDF

Info

Publication number
TW202123978A
TW202123978A TW109139151A TW109139151A TW202123978A TW 202123978 A TW202123978 A TW 202123978A TW 109139151 A TW109139151 A TW 109139151A TW 109139151 A TW109139151 A TW 109139151A TW 202123978 A TW202123978 A TW 202123978A
Authority
TW
Taiwan
Prior art keywords
hypochlorous acid
solution
anticancer agent
test
aqueous solution
Prior art date
Application number
TW109139151A
Other languages
English (en)
Chinese (zh)
Inventor
山下智榮子
中島勇一
Original Assignee
日商先端股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商先端股份有限公司 filed Critical 日商先端股份有限公司
Publication of TW202123978A publication Critical patent/TW202123978A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • A62D3/38—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by oxidation; by combustion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2101/00—Chemical composition of materials used in disinfecting, sterilising or deodorising
    • A61L2101/02—Inorganic materials
    • A61L2101/06—Inorganic materials containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10—Apparatus features
    • A61L2209/13—Dispensing or storing means for active compounds
    • A61L2209/132—Piezo or ultrasonic elements for dispensing

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW109139151A 2019-11-11 2020-11-10 抗癌劑暴露防止方法 TW202123978A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-203722 2019-11-11
JP2019203722 2019-11-11

Publications (1)

Publication Number Publication Date
TW202123978A true TW202123978A (zh) 2021-07-01

Family

ID=75912915

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109139151A TW202123978A (zh) 2019-11-11 2020-11-10 抗癌劑暴露防止方法

Country Status (5)

Country Link
JP (1) JPWO2021095696A1 (cg-RX-API-DMAC7.html)
KR (1) KR20220084109A (cg-RX-API-DMAC7.html)
CN (1) CN114728189A (cg-RX-API-DMAC7.html)
TW (1) TW202123978A (cg-RX-API-DMAC7.html)
WO (1) WO2021095696A1 (cg-RX-API-DMAC7.html)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53125312A (en) 1977-04-07 1978-11-01 Kajima Corp Method of placing underground wall
GB9323399D0 (en) * 1993-11-12 1994-01-05 Univ Newcastle Ventures Ltd Pharmaceutical formulations
DE69840706D1 (de) * 1997-11-11 2009-05-14 Takara Bio Inc Arzneimittel, speisen oder getränke mit physiologisch aktiven stoffen aus algen
US6092445A (en) 1999-04-29 2000-07-25 Skackelford; Jerry Lynn Telescoping die holder
JP2003169842A (ja) * 2001-12-04 2003-06-17 Sony Corp 次亜塩素酸水溶液による殺菌方法および殺菌装置
MXPA04009412A (es) * 2002-03-28 2005-12-12 Oxis Int Inc Metodos neuroprotectores, composiciones y metodos para seleccion de los mismos.
JP2006081802A (ja) * 2004-09-17 2006-03-30 Technomax:Kk 次亜塩素酸含有水による悪臭物質収容施設の殺菌・消臭方法及びそれに用いる装置
TW200714276A (en) * 2005-10-12 2007-04-16 Chiayi University Method for producing anti-tumor compound, piceatannol
WO2010148004A1 (en) * 2009-06-15 2010-12-23 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
EP2558156B1 (en) * 2010-04-14 2017-11-01 Hypo-Stream Limited Device for preparing dilute disinfectant solution
JP5613900B2 (ja) * 2010-10-27 2014-10-29 学校法人 岩手医科大学 光触媒水性組成物及び該組成物を用いた抗がん剤分解法
JP3166522U (ja) * 2010-12-24 2011-03-10 ナナイロ株式会社 除菌消臭用噴霧器
JP6258600B2 (ja) 2013-05-08 2018-01-10 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company 輸液チューブセットおよびその使用方法
WO2014208428A1 (ja) * 2013-06-25 2014-12-31 株式会社タムラテコ 抗がん剤分解方法および抗がん剤分解装置
JP2018516964A (ja) * 2015-06-09 2018-06-28 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited 局所進行性または転移性である肝内もしくは肝外胆管または胆嚢のカルシノーマに罹患する患者を治療する方法
KR102709765B1 (ko) 2016-03-28 2024-09-26 어플라이드 머티어리얼스, 인코포레이티드 서셉터 지지부
KR102329676B1 (ko) 2017-05-17 2021-11-19 엘지전자 주식회사 스마트 비데 및 이를 포함하는 제어 시스템
JP2020174900A (ja) * 2019-04-18 2020-10-29 緒方 康夫 抗癌剤を分解するための薬剤および方法

Also Published As

Publication number Publication date
WO2021095696A1 (ja) 2021-05-20
JPWO2021095696A1 (cg-RX-API-DMAC7.html) 2021-05-20
CN114728189A (zh) 2022-07-08
KR20220084109A (ko) 2022-06-21

Similar Documents

Publication Publication Date Title
Chen et al. Nanocatalytic biofunctional MOF coating on titanium implants promotes osteoporotic bone regeneration through cooperative pro-osteoblastogenesis MSC reprogramming
dos Santos Jr et al. A new “silver-bullet” to treat caries in children–nano silver fluoride: a randomised clinical trial
JP6771512B2 (ja) 抗不安薬組成物、製剤および使用方法
Hadrup et al. Toxicological risk assessment of elemental gold following oral exposure to sheets and nanoparticles–a review
DE102005035472A1 (de) Chemische Dialysatformulierungen auf Citratbasis
WO2005016234A2 (en) Compositions, methods, apparatuses, and systems for singlet oxygen delivery
Hu et al. Combinatorial low dose arsenic trioxide and cisplatin exacerbates autophagy via AMPK/STAT3 signaling on targeting head and neck cancer initiating cells
CN110013478A (zh) 用于抗肿瘤试剂施用的方法
TR201811221T4 (tr) Dişi gastroparezi ile ilişkili semptomların tedavisi.
CN105434351A (zh) 一种复方醋酸氟轻松新型喷雾剂及其制备方法
Raza et al. Review on harnessing silver nanoparticles for therapeutic innovations: A comprehensive review on medical applications, safety, and future directions
CA2848895C (en) Treatment of compartment syndrome
WO2021095696A1 (ja) 抗がん剤曝露防止方法
JP2020174900A (ja) 抗癌剤を分解するための薬剤および方法
Lachenmeier Antiseptic drugs and disinfectants
US20110077572A1 (en) Medical Equipment and Products using Chlorine, Hydrogen Peroxide, and Anti-Viral, Anti-Bacterial, Anti-Fungal, Agents, usage Method Improvements Dread Disease Cures, Remissions, and Anti-Infective Treatment Measures, Disease Treatment and Prevention System
JP2024090489A (ja) 抗がん剤分解液
González-Ventosa et al. Measures to prevent the risks associated with exposure to cytostatic drugs in glaucoma filtering surgery
JP2024064799A (ja) 抗がん剤分解液及びこれを用いた抗がん剤分解方法
TW436287B (en) Pharmaceutical composition for intramuscular administration comprising N-substituted benzamides, phenothiazines and their acid addition salts
US11260110B2 (en) Nanoparticles for the therapeutic treatment of radiation-induced skin ulcers
JP2019210237A (ja) 水素を含む加齢黄班変性治療用組成物
Lachenmeier Side effects of antiseptic drugs and disinfectants with experience of the third year of COVID-19
Pitello et al. Approaches for administering chemotherapy in the intensive care unit
Davis et al. Chemotherapy and hormonal therapy